Posts in Bayh-Dole


Want a greater ROI for taxpayers? Restore the patent system, protect Bayh-Dole and cut the red tape strangling federal labs

Three events boosted our economic turnaround in the 1980's: the passage of Bayh-Dole, which injected the incentives of patent ownership into the federal R&D system; the …
By Joseph Allen
1 month ago 5

Unleashing American Innovation, Oil States and Eroom’s Law

NCATS is working with industry to de-risk promising therapies by helping to take them further down the development pipeline. But the key ingredient remains finding a private …
By Joseph Allen
4 months ago 7

Commerce Secretary ready to push update to tech transfer laws to ensure greater commercialization

Secretary Ross gave an unequivocal endorsement of Bayh-Dole specifically, and more generally saying laws need to be updated to address business and technology realities of today, and …
By Gene Quinn
4 months ago 1

AUTM Licensing Survey: Ominous trend likely attributable to eroding patent rights

Concerns about the ability of academic institutions to keep contributing to the U.S. innovation economy go well beyond federal funding stagnation according to the recent AUTM …
By Steve Brachmann
7 months ago 0

Another IP Professor Attack On Patenting

I was just thinking how often someone teaching intellectual property law leads the attack on the patent system when "Racing for academic glory and patents: Lessons from …
By Joseph Allen
9 months ago 21

When Big Brother Comes Marching In: Patent Challenges on Entrepreneurial Campuses

Bayh-Dole has recently come under attack, as some are trying to highjack certain provisions to be used as a cost control measure for novel therapeutics as the …

Pity the Patients if Exclusive Licensing is Undermined

We've learned from experience that just because a theory's off base doesn't mean it won't take root, particularly when it involves patents and medicine. "No Vaccines Before …
By Joseph Allen
10 months ago 1

Think Twice Before Pulling the Plug on Tech Transfer

Most assaults on public/private sector R&D partnerships are launched by those who believe patents are inherently bad and that through some undefined magic publicly funded …
By Joseph Allen
11 months ago 0

Conservatives’ Letter to U.S. Senate Says Preserve Bayh-Dole

Though aimed at certain pharmaceutical products, Sens. Angus King’s and Bernie Sanders’ potential amendments would throw the key to the Bayh-Dole Act’s success —certainty and …
By James Edwards
11 months ago 0

Bernie Sander’s Really Bad Idea

Sen. Bernie Sanders (I-VT) introduced legislation requiring every agency and non-profit entity to include a "reasonable pricing" provision based on King's formula for any life science invention …
By Joseph Allen
12 months ago 14

Proposal from Senator King Won’t Reduce Drug Prices, Just Innovation

Many were stunned to learn that Senator Angus King (I-ME) included language undermining the Bayh-Dole Act in the report of the Senate Armed Services Committee as it …
By Joseph Allen
1 year ago 3

Academic Patent Licensing Helps Drive the U.S. Economy

What's even more impressive is the impacts on gross industry output and GDP are up 14% while  the number of U.S. jobs supported rose 12% since the previous …
By Joseph Allen
1 year ago 8

Want to Revive the Economy? Restore the Patent System!

The old arguments that patents inhibit innovation, and non-exclusivity with compulsory licensing leads to a brave new world are now in vogue. We've stood at this fork …
By Joseph Allen
1 year ago 17

Early Stage Innovation’s Chance to Save Itself

Universities in particular must explain to their congressional delegations why R&D must continue to be funded and why its Bayh-Dole based commercialization bridge must be protected …
By Chris Gallagher
1 year ago 0

The National Cancer Institute Didn’t Deserve This Treatment From the New York Times

While those in the military are often thanked for their service, let's also thank researchers like Dr. Rosenberg and his colleagues who spend their lives trying to …
By Joseph Allen
2 years ago 2

Our website uses cookies to provide you with a better experience. Read our privacy policy for more information.Accept and Close